23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 ...

Genetic testing company 23andMe, once a Silicon Valley darling valued at $6 billion, filed for Chapter 11 bankruptcy protection late Sunday as it prepares for a sale of the business. CEO Anne Wojcicki ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. The assets of failed DNA testing firm 23andMe are being bought for $256 million. Biotechnology firm ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. Bay Area-based 23andMe ...

On March 23, 2025, genetic testing company 23andMe announced it filed for bankruptcy — sparking a firestorm of articles and online posts advising consumers to delete their personal data in order to ...

The genetic testing company has filed for bankruptcy protection and it's unclear what will happen to its massive collection of customer data. Bree Fowler writes about cybersecurity and digital privacy ...

23andMe is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major data breach last year that affected roughly half of its customers. The ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based 23andMe ...

Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...